1-4 of 4
Mona Melhem
Close
Sort by
Journal Articles

Clinical and Pathological Prognostic Markers for Survival in Adult Patients with Post-Transplant Lymphoproliferative Disorders (PTLD), BCL2 Is a Poor Prognostic Marker in PTLD.

Ana B. Oton, MD, Hong Wang, Mona Melhem, MD, Diane George, Irene M. Ghobrial, MD
Journal: Blood
Blood (2006) 108 (11): 2035.
https://doi.org/10.1182/blood.V108.11.2035.2035
Published: 2006
Journal Articles

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Irene M. Ghobrial, MD, Mona Melhem, Ujjal Singha, PhD, Diane George, PhD, Michael Timm, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. D. Roodman, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2492.
https://doi.org/10.1182/blood.V106.11.2492.2492
Published: 2005
Journal Articles

Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques.

Yazan Alsayed, MD, Alexey Leontovich, PhD, Michael Timm, BS, Mona Melhem, MD, Michael Nalesnik, MD, Diane George, BS, Ujjal Singha, PhD, Alissa Huston, MD, Lanie Francis, MD, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Ronald Herberman, MD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2005) 106 (11): 286.
https://doi.org/10.1182/blood.V106.11.286.286
Published: 2005
Journal Articles

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Irene M. Ghobrial, MD, Mona Melhem, MD, Ujjal Singha, PhD, Diane George, Michael Timm, MD, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. David Roodman, MD, PhD, Philip Greipp, MD, Morie Gertz, MD, Thomas Witzig, MD
Journal: Blood
Blood (2005) 106 (11): 993.
https://doi.org/10.1182/blood.V106.11.993.993
Published: 2005